Related Experiment Video
Updated: Jan 24, 2026

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology
Published on: February 25, 2022
A RARE CAUSE OF PITUITARY APOPLEXY: CABERGOLINE THERAPY
1Adiyaman State Hospital, Endocrinology and Metabolic Disease, Adiyaman, Turkey.
Abstract:
Pituitary apoplexy (PA) is a life-threatening clinical syndrome. Dopamine receptor agonists are the drugs of choice in the treatment of prolactinomas. The use of cabergoline is reported to cause an increased risk of PA, particularly in macroprolactinomas of cystic nature. In this report, we present a patient with a cystic macroprolactinoma who developed PA on the 16th week of cabergoline treatment.
Related Concept Videos
Hypothalamic-Pituitary Axis
Hormones of the Pituitary Gland
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
The Pituitary Gland
Gene Therapy
Group Therapy
Psychodynamic Therapy

